Clinical Trial

TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The investigators assessed the effect of TNF-α antagonism within 6 hours of return of spontaneous circulation on 30-day mortality in patients who remained comatose after cardiopulmonary resuscitation (CPR) following cardiac arrest . In addition, the investigators explored the role of this treatment in modulating the systemic inflammatory response and its potential impact on 90- and 180-day morbidity and mortality and neurological outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-15.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-06-09
Trial Details
NCT Number NCT07176754
Lead Sponsor Peking University Third Hospital
Collaborators: Peking University First Hospital, Peking University People's Hospital, Peking University Shenzhen Hospital, Qilu Hospital of Shandong University, Jiangsu Provincial People's Hospital, Hunan Provincial People's Hospital, Sichuan Provincial People's Hospital, People's Hospital of Guangxi Zhuang Autonomous Region, People's Hospital of Xinjiang Uygur Autonomous Region, Zhongnan Hospital
Conditions Cardiac Arrest (CA), Post Cardiac Arrest Syndrome
Enrollment 208 participants
Start Date 2025-10-01
Primary Completion 2028-07-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-10